Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions

Meet our CEO

"At the end of the day, there is a patient at the center of our work and we all must share the commitment to treat every sample – their sample – as if a life depends on it." Costa Panagos, CEO Q2 Solutions

Costa PanagosCosta Panagos is chief executive officer and Board member of Q2 Solutions, a Quintiles Quest joint venture. Launched in 2015, Q2 Solutions is a leading global clinical trials laboratory services organization. The company helps biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. 

Previously, Costa was senior vice president and global head of QuintilesIMS’ Global Laboratories, which included its Central Laboratory, BioAnalytical and ADME operations as well as its Cardiac Safety Services organization. During his more than 15-year career at QuintilesIMS, Costa has held several leadership roles within the company’s Sales and Customer Solutions Management Groups, including leading its Global Sales Operations organization as well as serving as global lead for several large, strategic accounts. Prior to QuintilesIMS, Costa held various roles in the pharmaceutical division at Bayer. Outside of his professional career, Costa is active in his local community and serves as director for the North Carolina Public School Forum.

Costa earned a bachelor of science in biology from Brown University and his MBA from the University of Chicago, Booth School of Business. 

Listen to CEO Costa Panagos talk about Q2 Solutions and how we are creating the lab of the future.




Learn more about how our values inspire our employees to deliver on our customer promise to provide Actionable Insights for Better Health.  
Q2 Solutions Corporate Brochure

Learn who we are, what we do, and how we impact customers through the lens of our vision, mission, values, behaviors, and brand promise.

The Power of the Central Laboratory for Immuno-Oncology Drug Development

Lab of the Future

How the lab of the future provides scientific, technological, and operational expertise to improve outcomes

Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

Read More